Genpact SVP granted 6,928 common shares

Genpact LTD reported that Senior Vice President Sameer Dewan acquired 6,928 common shares through a grant/award transaction at a price of $0.00 per share.

Rhea-AI Filing Summary

Genpact LTD reported that Senior Vice President Sameer Dewan acquired 6,928 common shares through a grant/award transaction at a price of $0.00 per share. Following this award, he directly holds 61,207 common shares.

These shares relate to performance share units granted on March 15, 2023, for which the performance conditions have been satisfied. Each unit represents the right to receive one common share, and the units will vest on March 10, 2026, subject to his continued service.

Insider Trade Summary

Grant/Award: 6,928 shares

Grant/Award 1 txn

Insider Dewan Sameer

Role Senior Vice President

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	6,928	$0.00	$0.00

Holdings After Transaction: Common Shares — 61,207 shares (Direct)

Footnotes (1)

1. F1. The reporting person was granted performance share units (PSUs) on March 15, 2023 that were subject to performance conditions which have been satisfied. Each PSU represents the contingent right to receive one common share. The PSUs will vest on March 10, 2026 subject to the reporting person's continued service through such date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Genpact (G) report for Sameer Dewan?

Genpact reported that Senior Vice President Sameer Dewan acquired 6,928 common shares through a grant or award. The shares are tied to previously granted performance share units with satisfied performance conditions and will vest subject to continued service.

How many Genpact (G) shares does Sameer Dewan hold after this Form 4?

After this transaction, Senior Vice President Sameer Dewan directly holds 61,207 common shares of Genpact. This total reflects the addition of 6,928 granted shares reported in the Form 4 insider filing as a non-derivative acquisition.

What is the nature of the 6,928 Genpact (G) shares acquired by Sameer Dewan?

The 6,928 shares represent a grant or award acquisition linked to performance share units. Each performance share unit corresponds to one common share, with performance conditions already satisfied and vesting contingent on continued service through March 10, 2026.

At what price were the 6,928 Genpact (G) shares granted to Sameer Dewan?

The 6,928 common shares acquired by Senior Vice President Sameer Dewan were reported at a price of $0.00 per share. This reflects a compensatory equity award rather than an open-market purchase transaction for cash consideration.

When were the performance share units for Sameer Dewan of Genpact (G) originally granted?

The performance share units were originally granted on March 15, 2023. These units are now tied to 6,928 common shares, with performance conditions satisfied and vesting scheduled for March 10, 2026, subject to Sameer Dewan’s continued service.

When will the Genpact (G) performance share units for Sameer Dewan vest?

The performance share units will vest on March 10, 2026, assuming continued service by Senior Vice President Sameer Dewan. Upon vesting, each unit provides the right to receive one Genpact common share, consistent with the terms described.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/05/2026 - 04:43 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dewan Sameer

(Last) (First) (Middle)

C/O GENPACT LLC

521 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK NY 10175

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior Vice President

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	03/03/2026		A		6,928(1)	A	$0	61,207	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person was granted performance share units (PSUs) on March 15, 2023 that were subject to performance conditions which have been satisfied. Each PSU represents the contingent right to receive one common share. The PSUs will vest on March 10, 2026 subject to the reporting person's continued service through such date.

Remarks:

	/s/ Thomas D. Scholtes, as Attorney-in-fact for Sameer Dewan	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.